NLRP3 and CINCA syndrome: Further, FCAS retained the highest proportion of moderately-disruptive mutations among CAPS NLRP3-AIDs and still had more severely-disruptive mutations compared to CINCA/NOMID (Figure 2E), suggesting an inverse relationship between disruptive potential and disease severity.